Trials / Conditions / Unclassified Renal Cell Carcinoma
Unclassified Renal Cell Carcinoma
5 registered clinical trials studyying Unclassified Renal Cell Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC NCT04413123 | Bradley A. McGregor, MD | Phase 2 |
| Active Not Recruiting | Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) f NCT04071223 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma NCT03635892 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Active Not Recruiting | Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcino NCT03541902 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy NCT03055013 | National Cancer Institute (NCI) | Phase 3 |